Sousa V et al., 2019-11-13: Portuguese comparison of new porphyrin photosensitisers against methylene blue for inactivating Candida albicans in plasma and whole blood; the new compounds did better in whole blood than methylene blue.
only three photosensitizers (PSs) have been approved, methylene blue (MB) for plasma and riboflavin and amotosalen for plasma and platelets.
Abstract
Sousa V et al., 2019-11-13: Portuguese comparison of new porphyrin photosensitisers against methylene blue for inactivating Candida albicans in plasma and whole blood; the new compounds did better in whole blood than methylene blue. Study type: in vitro (C. albicans in plasma and whole blood; haemolysis assays). Country: Portugal (University of Aveiro, Coimbra). Comparator: methylene blue as the approved reference photosensitiser; also riboflavin and amotosalen context. Funding: FCT UID/QUI/00062/2019, UID/AMB/50017/2019, PTDC/ASPPES/29576/2017, COMPETE 2020. Conflicts: none declared. Bearing: the approved-status sentence supports the regulatory claim in C2; the result itself shows MB is not the best fungal photosensitiser in whole blood. Study type: lab.
